Evidence map›Paper›PMID 32760623›Full record

ArticleCureus2020

Rate and Modifiable Predictors of 30-Day Readmission in Patients with Acute Respiratory Distress Syndrome in the United States.

Harshil Shah, Uvesh Mansuri, Sukrut Pagad, Reshmi Adupa, Jagmeet Singh, Khin Tun, Chail Shah, Solomon Tuonuur, Priyal J Shah, Mir Z Ali Khan and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Harshil ShahInternal Medicine, Independent Researcher, Sayre, USA.
Uvesh MansuriMedicine, MedStar Union Memorial Hospital, Baltimore, USA.
Sukrut PagadInternal Medicine, Larkin Community Hospital, Hialeah, USA.
Reshmi AdupaInternal Medicine, Garden City Hospital, Garden City, USA.
Jagmeet SinghNephrology, Geisinger Commonwealth School of Medicine, Scranton, USA.
Khin TunPediatrics, Independent Researcher, Yangon, MMR.
Chail ShahInternal Medicine, Brooklyn Cancer Care, Brooklyn, USA.
Solomon TuonuurInternal Medicine, University of New Haven, Meriden, USA.
Priyal J ShahInternal Medicine, The Medical Center, Navicent Health, Macon, USA.
Mir Z Ali KhanInternal Medicine, Mercy Catholic Medical Center, Darby, USA.
Gurjot S GrewalMedicine, Christian Medical College & Hospital, Ludhiana, IND.
Ruchir GoswamiEpidemiology and Public Health, Icahn School of Medicine at Mount Sinai, New York, USA.
Shantanu SolankiHospital-Based Medicine, Geisinger Commonwealth School of Medicine, Scranton, USA.
Catholic Medical Center · USIcahn School of Medicine at Mount Sinai · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The 30-day readmission rates are being used as a quality measure by Centers for Medicare and Medicaid Services (CMS) for specific medical and surgical conditions. Acute respiratory distress syndrome (ARDS) is one of the important causes of morbidity and mortality in the United States (US). The characteristics and predictors of 30-day readmission in ARDS patients in the US are not widely known, which we have depicted in our study. Objective The aim of this study is to identify 30-day readmission rates, characteristics, and predictors of ARDS patients using the largest publicly available nationwide database. Methods We used the National Readmission Database from the year 2013 to extract the patients with ARDS by primary discharge diagnosis with ICD9-CM codes. All-cause unplanned 30-day readmission rates were calculated for patients admitted between January and November 2013. The independent predictors for unplanned 30-day readmission were identified by survey logistic regression. Results After excluding elective readmission, the all-cause unplanned 30-day readmission rate for ARDS patients was 18%. Index admissions readmitted within 30-day had a significantly higher baseline burden of comorbidities with a Charlson Comorbidity Index (CCI) ≥1 as compared to those who were not readmitted within 30 days. In multivariate regression analysis, several predictors associated with 30-day readmission were self-pay/no charge/other (OR 1.19, 95%CI: 1.02-1.38;

Indexed as

acute respiratory distress syndromepredictorsreadmission

Identifiers

PMID32760623
PMCPMC7392362
OpenAlexW3038424276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.